Advancing cancer immunotherapy by targeting the unconventional

The Enara Bio™ purpose

Shining a light on Dark Antigen™ and T-cell biology to enable people to live free from the shadow of cancer. Our mission is to advance novel T-cell receptor (TCR) directed immunotherapies against unconventional, shared, cancer-specific antigens designed to treat a broad patient population.

To achieve our mission, we have built a differentiated technology platform integrating bioinformatics, immunopeptidomics, metabolomics and immunology that enables us to interrogate both sides of the T-cell/cancer cell interface. Our growing team has the depth of expertise and breadth of experience to advance this exciting area of immuno-oncology for the benefit of broad groups of cancer patients and their families.

Read more about us

Who we are

We are a diverse, experienced, and rapidly growing team driven by a common purpose and united by our shared values. The culture we have developed enables each of us to make an impact and deliver on our vision.

Introducing Enara Bio Poster

Latest News